Clinical Trial Update: An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for MT-3995 in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• MT-3995

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED